INTRODUCTION
Low back pain has been reported to affect 60-70% of adults during their lifetime and is a regular cause for seeking medical care [1, 2] . Low back pain is defined as chronic if symptoms persist for more than 3 months. Although chronic low back pain is most often degenerative, in about 5% of patients, the pain results from inflammation [3, 4] and is referred to as inflammatory back pain (IBP).
One of the causes of IBP is axial spondyloarthritis (SpA), of which the prevalence is approximately 0.5-1% in the general population [5] [6] [7] [8] . Chronic IBP has been identified as a major clinical feature of SpA and is experienced by most patients, whereas other peripheral or extra-articular manifestations (inflammation of peripheral joints with asymmetrical arthritis, predominantly of the lower limb; occurrence of enthesitis; uveitis) are present in approximately 40-60% of patients [6] . Axial SpA refers to patients with predominant axial involvement and axial complaints, and includes both ankylosing spondylitis (AS), for which evidence of sacroiliitis (another hallmark of SpA) is detected on X-rays, and non-radiographic axial SpA, where sacroiliitis is visible via magnetic resonance imaging (MRI) but not on X-rays [6] . Evidence has been gathered that non-radiographic axial SpA might be an early stage of AS, although not all cases of axial SpA will progress to AS [9, 10] . A strong association with Human Leucocyte
Antigen-B27 (HLA-B27) has also been evidenced
[11] and can be considered as the third main clinical feature of axial SpA. [17] . Facilitating an early diagnosis is therefore among the objectives clearly identified by ASAS to improve patient well-being [14, 18] .
Some studies have highlighted the lack of awareness among general practitioners, especially regarding the disease spectrum and early detection [3, 19] . One strategy to shorten the delay between the occurrence of first symptoms and the final diagnosis of AS is to increase the awareness of SpA and AS among primary healthcare professionals and non-rheumatologist specialists, providing them with tools to identify these patients among the large population of patients with back pain. Recently, several referral strategies, mostly intended for general practitioners and primary care professionals, have been developed to allow earlier diagnosis [2, 10, 20, 21] . The SUSPECT study was designed to evaluate whether real-life screening of patients with chronic back pain who consult PMR physicians, orthopedists, and ophthalmologists is useful in detecting axial SpA.
METHODS

Protocol Overview and Study Design
The SUSPECT study was approved by the ethics committee of Erasme Hospital (Brussels, Belgium) and conducted according to local Demographic and baseline characteristics (duration of pain, presence of IBP symptoms, and SpA features) were collected during a single routine visit on a first case report form (CRF). given for information purposes only; these data should be considered with caution.
Outcome Measures
The proportion of patients with confirmed diagnosis of axial SpA was evaluated and the characteristics of the patients referred to a rheumatologist were summarized.
Statistical Analysis
Descriptive analyses were performed using the SAS package for Windows, version 9.2 (SAS, Cary, NC, USA) on the full analysis set, which consisted of all enrolled patients with available information. Five subpopulations were defined:
patients referred to a rheumatologist, patients agreeing to visit a rheumatologist, patients for whom feedback from the rheumatologist was available, patients with confirmed SpA diagnosis and patients with confirmed diagnosis not meeting the referral criteria (see flow chart in Fig. 1 for more details).
RESULTS
Patient Demographics
A total of 27 investigators (three orthopedists, six ophthalmologists, and 18 PMR physicians) recruited 161 patients meeting the eligibility criteria for the study (patients aged between 18 and 45 years old, with chronic back pain and pain at night, having signed an informed consent and without known axial SpA). 
Characteristics of Patients with Confirmed Axial SpA Diagnosis
In general, rheumatologists felt confident with their diagnosis (mean score [7 on a 0-10 scale).
The main characteristics of patients with confirmed diagnosis of axial SpA are presented in Table 2 . The mean age (34, SD: 8 years), sex ratio (41% male), and mean back pain duration 
DISCUSSION
In the SUSPECT study, 117 patients were referred to a rheumatologist (73% of the 161 enrolled patients) and diagnosis was confirmed for 37 patients, i.e., 23% of the enrolled patients and 32% of the referred patients. This proportion is similar to the prevalence observed in the literature [2, 8, 20, 22- IBP inflammatory back pain, n number of patients in the specified category [29] .
When the ASAS classification criteria for axial SpA were applied, 89% of the patients with confirmed diagnosis (33/37 patients) were classified as having axial SpA: one-third via the clinical arm of the ASAS criteria, which shows the importance of this arm for early diagnosis of axial SpA. These results are more or less in line with the results observed in 2 cohort studies, the DESIR and the SPACE cohorts [31, 32] , which reported that 40% and 50% of patients, respectively, met the clinical arm criteria.
This study had several limitations; therefore, the results should be interpreted with caution.
They are, however, mostly supportive of the current literature and informative for any healthcare professional dealing with early diagnosis of SpA. Because of the non-interventional nature of the study, it was not mandatory for the orthopedist, PMR physician or ophthalmologist to refer all patients included in the study to a rheumatologist. This might have led to a selection bias in the estimation of axial SpA in patients with chronic back pain. The fact that CRP C-reactive protein, ESR erythrocyte sedimentation rate, HLA human leukocyte antigen, IBP inflammatory back pain, n number of patients in the specified category, NSAID nonsteroidal anti-inflammatory drug, SD standard deviation, SpA axial spondyloarthritis a HLA-B27 was not systematically requested by the investigator or rheumatologist but was only collected in the CRF when results were available. Therefore the proportion of patients with positive HLA-B27 results is not presented (total number of patients tested for HLA-B27 and number of patients with negative HLA-B27 results is unknown) 
